[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356293-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356293-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","inherited-resilience-to-clonal-hematopoiesis-by-modifying-stem-cell-rna-regulation","Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation","","Somatic mutations that enhance hematopoietic stem cell fitness promote clonal hematopoiesis and increase susceptibility to blood cancers. Population differences in mutant-clone growth and potential imply that genetic variation can shape resilience to clonal hematopoiesis. The study identifies a noncoding regulatory variant, rs17834140-T, that reduces clonal hematopoiesis and myeloid malignancy risk by selectively lowering MSI2 RNA-binding protein activity in HSCs, and links the variant to an MSI2-dependent RNA regulatory network affecting HSC maintenance and clonal expansion.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/inherited-resilience-to-clonal-hematopoiesis-by-modifying-stem-cell-rna-regulation/356293/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/inherited-resilience-to-clonal-hematopoiesis-by-modifying-stem-cell-rna-regulation/356293.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in clonal hematopoiesis research?","Question",{"text":63,"@type":64},"It addresses how somatic mutations drive the expansion of hematopoietic stem cells in clonal hematopoiesis and how genetic factors may confer resilience against this process and related blood cancers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which genetic variant is identified as protective?",{"text":68,"@type":64},"The study identifies a noncoding regulatory variant, rs17834140-T, that protects against clonal hematopoiesis and myeloid malignancies.",{"name":70,"@type":61,"acceptedAnswer":71},"How does rs17834140-T exert its protective effect on stem cells?",{"text":72,"@type":64},"It protects by selectively down-regulating the RNA-binding protein MSI2 in hematopoietic stem cells, with downstream effects supported by mapping of MSI2 binding targets and an RNA network influencing clonal risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356293,1790457793,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Author Manuscr ipt Author Manuscr ipt Author Manuscr ipt Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Science. Author manuscript; available in PMC 2026 January 29. |\n| --- | --- |\n\nPublished in final edited form as:  \nScience. 2026 January ; 391(6780): 52–58. doi:10.1126/science.adx4174 .  \nInherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation  \nGaurav Agarwal 1,2,3,4 , Mateusz Antoszewski 1,2,3,4 , Xueqin Xie5 , Yash Pershad6 , Uma P. Arora 1,2,3,4 , Chi-Lam Poon7 , Peng Lyu 1,2,3,4 , Andrew J. Lee 1,2,3,4 , Chun-Jie Guo 1,2,3,4 , Tianyi Ye 1,2,3,4 , Laila Barakat Norford 1,2,3,4,8 , Anna-Lena Neehus 1,2,3,4 , Lucrezia della Volpe 1,2,3,4 , Lara Wahlster1,2,3,4 , Diyanath Ranasinghe9 , Tzu-Chieh Ho5,†, Trevor S. Barlowe5 , Arthur Chow5 , Alexandra Schurer5,‡, James Taggart5,§ , Benjamin H. Durham5,¶ , Omar AbdelWahab5 , Kathy L. McGraw 10,11,12 , James M. Allan9 , Ruslan Soldatov7 , Alexander G. Bick6 , Michael G. Kharas5,* , Vijay G. Sankaran 1,2,3,4,13,*  \n1 Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA.  \n2 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.  \n3 Howard Hughes Medical Institute, Boston Children’s Hospital, Boston, MA, USA.  \n4Broad Institute of MIT and Harvard, Cambridge, MA, USA.  \n5Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.  \nThis work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.  \n*C†Poreespondnt addingresas:uthDoepra. sanrtmanrtaonf@Proadiatdriiss,tiItundteia.onU(Vni.Gve.Srs.i)t;ykhSacrahol @ofmMskcedicc.i,(MInd.iGan.Kap.. lis, IN, USA.  \n‡Present address: Albert Einstein College of Medicine, Bronx, NY, USA.  \n§Present address: Department of Systems Biology, Harvard Medical School, Boston, MA, USA.  \n¶Present address: Departments of Pediatrics and Pathology and Laboratory Medicine, Rutgers Cancer Institute, New Brunswick, NJ, USA.  \nAuthor contributions: Conceptualization: G.A., M.G.K., V.G.S.; Methodology: G.A., M.G.K., V.G.S.; Experiments: G.A., M.A., X.X., P.L., L.d.V., T.-C.H., T.S.B., A.C., A.S., J.T.; Computational analyses: G.A., Y.P., C.-L.P., A.J.L., L.B.N., D.R., K.L.M.; Resources and feedback: C.-J.G., T.Y., A.-L.N., L.d.V., L.W., B.H.D., O.A.-W., J.M.A., R. S., A.G.B. ; Visualization: G.A., Y.P.,  \nU.P.A., A.J.L., M.G.K., V.G.S.; Funding acquisition: V.G.S., M.G.K.; Supervision: V.G.S., M.G.K.; Writing – original draft: G.A., V.G.S.; Writing – review & editing: G.A., V.G.S., with input from all authors.  \nCompeting interests: O.A.-W. is a founder and scientific advisor of Codify Therapeutics and holds equity and receives research funding from this company. O.A.-W. has served as a consultant for Amphista Therapeutics and MagnetBio and is on scientific advisory boards of Envisagenics Inc. and Harmonic Discovery Inc.; O.A.-W. received research funding from Nurix Therapeutics, Minovia Therapeutics, and LOXO Oncology, unrelated to this work. M.G.K. serves as an advisor to 858 Therapeutics, Inc., and receives funding from AstraZeneca and Transition Bio, Inc., all unrelated to this work. V.G.S. serves as an advisor to Ensoma and Cellarity, unrelated to this work. All other authors declare that they have no competing interests.  \nData, code and materials availability: All raw data for CD34+ MSI2-HyperTRIBE are available from European Nucleotide Archive (ENA) under study accession no. ERP182264. All raw data for scRNA-seq (GSE291294) and related code are available in our GitHub repository ([https://github.com/sankaranlab/chip_resilience](https://github.com/sankaranlab/chip_resilience)) and Zenodo (67). Bulk RNA-seq (GSE291293) experiments are available in the Gene Expression Omnib","cbCaim8e8mNdIXkz","https://ap.wps.com/l/cbCaim8e8mNdIXkz","pdf",2397379,38,"English","# Abstract\n## Key findings\n## Variant-to-mechanism mapping\n## Implications for resilience and clonal risk","[{\"question\":\"What problem does the study address in clonal hematopoiesis research?\",\"answer\":\"It addresses how somatic mutations drive the expansion of hematopoietic stem cells in clonal hematopoiesis and how genetic factors may confer resilience against this process and related blood cancers.\"},{\"question\":\"Which genetic variant is identified as protective?\",\"answer\":\"The study identifies a noncoding regulatory variant, rs17834140-T, that protects against clonal hematopoiesis and myeloid malignancies.\"},{\"question\":\"How does rs17834140-T exert its protective effect on stem cells?\",\"answer\":\"It protects by selectively down-regulating the RNA-binding protein MSI2 in hematopoietic stem cells, with downstream effects supported by mapping of MSI2 binding targets and an RNA network influencing clonal risk.\"}]","Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation | PDF",1790124467,96,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3e96db0ff4e44a8aa84d391fde06e18.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84aa0c0ef0035ef9a31cbff7449b9da1.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79f3a1042dc9848dfb39e6121cf2bb0f.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86b1713b70f8dcde5760a3385df5f246.webp",980,1268]